Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Zydus' Patel family buys stake in urban infra firm pivoting to healthcare
The Patel family, the promoters of public listed Zydus Lifesciences, has picked up a small stake in an urban ......
Healthcare
PE firms circle Tata Capital Healthcare-backed Linux Laboratories
Linux Laboratories Pvt Ltd, a pharmaceutical company focussed on central nervous system (CNS) therapies, is in talks ......
Healthcare
Temasek set to strike a new healthcare deal in India
Singapore's Temasek, which has backed Manipal Hospitals and Axis Bank, among others, is set to sign a new deal to ......
Healthcare
Tata Capital Healthcare Fund plots exit from another portfolio firm
Tata Capital Healthcare Fund, the healthcare and life sciences-focused private equity arm of Tata Capital Ltd, is ......
Healthcare
Biocon's Mazumdar-Shaw sets out 5-year transition plan, names niece Claire as successor
Biocon founder and chairperson Kiran Mazumdar-Shaw plans a gradual leadership transition over the next five years, with ......
Healthcare
Tata Capital Healthcare Fund set to close $30 mn deal
Tata Capital Healthcare Fund is all set to seal a deal in a Hyderabad-headquartered diagnostics chain that offers ......
Finance
Tech Mahindra, Bharat Forge, IIFL Fintech, Dr Lal PathLabs, others ink M&A deals
Four Indian companies announced acquisitions late on Thursday across IT services, auto components, diagnostics and ......
Healthcare
Bain Capital scripting a modest $350 mn exit from India portfolio firm
Bain Capital, a bulge-bracket global private equity firm which is believed to be nearing the final close of its new ......
Healthcare
Bottomline: Multiples PE-controlled Zenex sees growth decelerate but margins improve
IPO-bound Zenex Animal Health India Pvt Ltd may see a slowdown in revenue growth but its profitability is set to ......
Healthcare
Sun Pharma to acquire US-listed Organon in $11.75-bn deal
Sun Pharmaceutical Industries will acquire Organon & Co in an all‑cash deal, valuing the U.S. drugmaker at about $11.......









